search

Active clinical trials for "Hodgkin Disease"

Results 731-740 of 784

Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA),...

Malignant HaemopathiesAcute Leukemia2 more

Unicentric retrospective analysis of a cohort of 602 young adult and adolescent patients, aged 15 to 30 years, with haematological malignancies, and managed between 2000 and 2016

Completed2 enrollment criteria

Genetic Study of Families With High Frequency of Hodgkin Lymphoma

Hodgkin Lymphoma

Hodgkin lymphoma (HL) is a relatively rare disorder with known familiar aggregation (i.e. HL in more than one child, or parent and child). Because affected individuals in familial HL are genetically related, the existence of such families has long been considered as evidence in support of a genetic basis of HL susceptibility. However, it is largely unknown which genetic variations are responsible for recurring HL in families. Because the effects of genetic variants are likely to be strong in familial HL, identification of such variations will potentially reveal biological pathways critical to the pathogenesis of HL. PRIMARY OBJECTIVE: To perform genome-wide sequencing of families with recurring Hodgkin lymphoma cases (affected as well as non-affected family members) to identify potential disease-causing germline genetic variations. SECONDARY OBJECTIVE: To describe demographic and clinical features of the affected families.

Completed4 enrollment criteria

Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients

FatigueHodgkin Lymphoma

Fatigue is one of the most prevalent symptoms endorsed by cancer survivors, particularly those treated for breast cancer or Hodgkin lymphoma. Despite the tremendous implications such work has for effective interventions, little is known about the underlying pathophysiology of fatigue, association with medical co-morbidities and factors that may help predict those to be at highest risk. The proposed research will utilize Vanderbilt-Ingram Cancer Center REACH for Survivorship Program together with the investigators Hematologic Malignancies Program. In adolescent and young adults (AYA), ages 18 - 39 the investigators will address the following: Primary Aims Aim 1: Assess the prevalence and severity of fatigue and its impact on functional outcomes Aim 2: Determine host, disease and treatment-related risk factors for fatigue Secondary Aims Aim 1: Evaluate the association between levels of proinflammatory cytokine activity and fatigue Aim 2: Evaluate the association between fatigue and self reported fatigue in AYA Hodgkin lymphoma (HL) survivors. Hypotheses: Fatigue is more prevalent and severe among AYA HL patients and survivors, compared to general population and will be associated with impaired functional outcome. Risk factors for fatigue include higher disease stage, B symptoms and elevated erythrocyte sedimentation rate at diagnosis, dose density of chemotherapy and higher doses and more expanded fields of radiotherapy. Risk of fatigue is associated with long-term cardiopulmonary and endocrine complications. Levels of specified proinflammatory cytokines are associated with increased fatigue.

Completed8 enrollment criteria

MELT - MRI Evaluation of Lymphoma Treatment

LymphomaHodgkin

Patients who are newly diagnosed with Hodgkin's lymphoma will undergo disease staging at diagnosis and initial treatment response assessment. At each time point (initial staging and treatment response assessment) in addition to standard imaging investigations (PET CT, Chest CT, anatomical MRI of the abdomen and pelvis and abdominal USS), patients will undergo an extended MRI scan.

Completed6 enrollment criteria

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Hodgkin LymphomaNon Hodgkin Lymphoma3 more

This research is being done to determine whether viral thymidine kinase (TK) expression in Epstein-Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV) virus-associated tumors is sufficient to image.

Completed32 enrollment criteria

Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors

LymphomaNon-Hodgkins1 more

The aims and objectives of this research are to identify chronic health conditions, psychological disease, quality of life issues, and patient preferences for survivorship care in patients who have survived aggressive lymphoma. Subjects will be asked to participate in an oral interview with the primary investigator, either in-person or over the telephone. It is estimated that the survey will take about an hour.

Completed5 enrollment criteria

Quality of Life Among Survivors of Hodgkin Lymphoma

Hodgkin's Disease

The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.

Completed3 enrollment criteria

Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma

Ann Arbor Stage I Childhood Hodgkin LymphomaAnn Arbor Stage II Childhood Hodgkin Lymphoma3 more

This laboratory study is collecting and storing samples of tissue and blood from young patients with Hodgkin's lymphoma. Collecting and storing samples of tumor tissue and blood from patients with cancer to study in the laboratory may help the study of cancer in the future.

Completed3 enrollment criteria

Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy...

Hodgkin's Lymphoma

This is a retrospective analysis of a homogeneous cohort of patients with relapsed/refractory HL that received IGEV scheme as induction therapy to HDCT and AHSCT for reassess the most common prognostic factors and try to identify a prognostic score with clinical and therapeutic relevance by using 6 clinical tools: B symptoms(yes/no) relapse in previously irradiated areas(yes/no) Ann Arbor Stage (III/IV vs I/II) disease status at accrual (refractory vs relapsed) Early relapse within 12 months of Complete Response (CR) versus late relapse after Complete Response (CR) lasting > l2 months", extranodal involvement (yes/no).

Completed9 enrollment criteria

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease...

LymphomaPsychosocial Effects of Cancer and Its Treatment

RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment on patients with cancer. PURPOSE: This clinical trial studies the impact of therapy on the health status and quality of life of patients with stage I or stage II Hodgkin's disease who are receiving radiation therapy with or without chemotherapy.

Completed3 enrollment criteria
1...737475...79

Need Help? Contact our team!


We'll reach out to this number within 24 hrs